Data gathered: November 27
Alternative Data for Haemonetics Corporation
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 24,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 589 | Sign up | Sign up | Sign up |
| Twitter Mentions | 18 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Haemonetics Corporation
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
| Price | $87.84 |
| Target Price | Sign up |
| Volume | 294,500 |
| Market Cap | $4.44B |
| Year Range | $71.16 - $97.37 |
| Dividend Yield | 0% |
| PE Ratio | 36.71 |
| Analyst Rating | 88% buy |
| Industry | Medical Devices |
In the news
 |
Victory Capital Management Inc. Has $22.42 Million Stock Position in Haemonetics Co. (NYSE:HAE)November 19 - ETF Daily News |
 |
Needham & Company LLC Reiterates Buy Rating for Haemonetics (NYSE:HAE)November 18 - ETF Daily News |
|
Versor Investments LP Acquires 300 Shares of Haemonetics Co. (NYSE:HAE)November 16 - ETF Daily News |
 |
HAE or BSX: Which Is the Better Value Stock Right Now?November 15 - Yahoo |
|
Haemonetics (NYSE:HAE) Rating Increased to Strong-Buy at Raymond JamesNovember 12 - ETF Daily News |
 |
Here's Why Haemonetics (HAE) is a Strong Value StockNovember 11 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 346M | 286M | 187M | 34M | 81M | 1.120 |
| Q2 '24 | 350M | 303M | 175M | 38M | 69M | 1.020 |
| Q1 '24 | 1.63B | 320M | 176M | 20M | 68M | 0.900 |
| Q4 '23 | 336M | 287M | 178M | 31M | 68M | 1.040 |
| Q3 '23 | 318M | 272M | 171M | 25M | 57M | 0.990 |
Insider Transactions View All
| Strong Stewart W filed to sell 18,196 shares at $91.2. July 29 '24 |
| Lingamneni Anila filed to sell 21,331 shares at $90. July 15 '24 |
| Lingamneni Anila filed to sell 21,410 shares at $90. July 15 '24 |
| Strong Stewart W filed to sell 18,196 shares at $87.5. May 29 '24 |
| Basil Michelle L filed to sell 31,257 shares at $88.6. May 29 '24 |
Similar companies
Read more about Haemonetics Corporation (HAE) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Haemonetics Corporation?
The Market Cap of Haemonetics Corporation is $4.44B.
What is Haemonetics Corporation's PE Ratio?
As of today, Haemonetics Corporation's PE (Price to Earnings) ratio is 36.71.
What is the current stock price of Haemonetics Corporation?
Currently, the price of one share of Haemonetics Corporation stock is $87.84.
How can I analyze the HAE stock price chart for investment decisions?
The HAE stock price chart above provides a comprehensive visual representation of Haemonetics Corporation's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Haemonetics Corporation shares. Our platform offers an up-to-date HAE stock price chart, along with technical data analysis and alternative data insights.
Does HAE offer dividends to its shareholders?
As of our latest update, Haemonetics Corporation (HAE) does not offer dividends to its shareholders. Investors interested in Haemonetics Corporation should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Haemonetics Corporation?
Some of the similar stocks of Haemonetics Corporation are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.